Empowering Consumers Hurt by Big Businesses

Local (415) 319-8833
Toll Free (855) 534-0061

Dangerous Pharmaceuticals

Recent Posts in Dangerous Pharmaceuticals Category

  • Taxotere Hair Loss Lawsuit Filed

    Taxotere is the brand name of docetaxel, a chemotherapy medication used to treat various types of cancer, including cancer that affects the breasts, head and neck, stomach, prostate, and non small-cell lung. Like most chemotherapy drugs, it does have side effects most patients experience when injected with it, including low blood cell counts, numbness, shortness of breath, vomiting, muscle pain, ...
    Continue Reading
  • Heartburn Medication Linked to Stomach Cancer

    Heartburn medication is often used to control stomach acid and treat conditions such as heartburn, acid reflux, peptic ulcers, and other related health conditions. Millions of people nationwide use over-the-counter or prescription heartburn medication to help them reduce the most severe of symptoms of heartburn, which can be caused by certain foods, alcohol, or other related health problems. But ...
    Continue Reading
  • Chronic Heartburn Medication Can Cause Dangerous Side Effects

    Chronic heartburn is not a health condition that should be taken lightly. If unaddressed, it could cause significant damage to the stomach and esophagus, as well as lead to the development of certain cancers. Proton pump inhibitors (PPI) are drugs manufactured with the sole purpose of controlling heartburn and acid reflux disease. As useful as a PPI might be to some patients, new studies are ...
    Continue Reading
  • More Talcum Powder Lawsuits On the Horizon

    In early 2016, pharmaceutical giant Johnson & Johnson (J&J) was ordered by an Alabama court to pay $72 million in compensation to plaintiffs who claimed that a family member had died of ovarian cancer caused by her regular use of the company’s talcum powder products . A few months later, the company once again lost a similar lawsuit, which cited the same grounds, in South Dakota, resulting in a ...
    Continue Reading
  • FDA ISSUES RECALL NOTICE ABOUT MYLAN INJECTABLE PRODUCTS

    The FDA recently warned healthcare professionals of a recall of various injectable medications by Mylan N.V. These pharmaceuticals include gemcitabine, carboplatin, methotrexate, and cytarabine, which are mostly used to treat various types of cancer. Mylan has recalled certain lots of these injectable products that were distributed in 2014. The reason for the nationwide recall is "the presence of ...
    Continue Reading
  • ANTIPSYCHOTIC DRUG COULD CAUSE FATAL SKIN REACTIONS

    The FDA recently issued a safety warning about a serious condition associated with the use of the antipsychotic drug ziprasidone. Also marketed under the brand name Geodon, this drug is used to treat schizophrenia and bipolar disorder. The FDA warning cautions that taking ziprasidone could cause "a rare but serious skin reaction" known as DRESS. The condition could "start as a rash that can spread ...
    Continue Reading
  • FDA ISSUES RECALL NOTICE ABOUT CUBICIN

    The FDA recently warned healthcare professionals of a recall of Cubist Pharmaceuticals' Cubicin (daptomycin for injection). Cubicin is an intravenous antibiotic prescribed "for the treatment of skin infections and certain blood stream infections." Cubist Pharmaceuticals has recalled nine lots of Cubicin shipped between September 2013 and December 2013 due to the presence of foreign particulate ...
    Continue Reading
  • FDA WARNS AGAINST USING LIDOCAINE TO TREAT TEETHING PAIN

    The FDA recently issued a safety announcement alerting of serious risks associated with the use of lidocaine. Use of prescription oral viscous lidocaine to treat teething pain in infants and young children could result in grave harm, including death. The FDA is requiring a Boxed Warning, FDA's strongest warning, to be added to the drug label to highlight the risk of severe adverse reactions. The ...
    Continue Reading
  • WEIGHT LOSS DRUG COULD CAUSE CANCER AND CARDIAC PROBLEMS

    The FDA recently cautioned consumers not to purchase or use La Jiao Shou Shen, a product promoted as a weight loss supplement. A laboratory analysis conducted by the FDA confirmed the product contains the undeclared ingredients sibutramine and phenolphthalein. Sibutramine is a controlled substance that was removed from the market in 2010 due to safety concerns. Sibutramine can "interact, in ...
    Continue Reading
  • THE EUROPEAN MEDICINES AGENCY INITIATES REVIEW OF TESTOSTERONE PRODUCTS OVER CONCERNS ABOUT CARDIAC SIDE EFFECTS

    The European Medicines Agency (EMA) recently started a safety review of testosterone-containing products. The review was initiated at the request of the Estonian medicines agency due to concerns about harmful effects of testosterone therapy (TT) on the heart. These safety issues were raised in several recent publications that suggested significantly increased risk of heart attacks and other ...
    Continue Reading
  • HARVARD MEN'S HEALTH WATCH WARNS OF CARDIAC RISKS WITH TESTOSTERONE THERAPY

    The most recent issue of Harvard Men's Health Watch discusses the safety and risks associated with testosterone therapy (TT). The newsletter notes that millions of Americans undergo testosterone therapy, enticed by the myriad promises of lifestyle improvements offered by the "ongoing pharmaceutical marketing blitz." However, there are "legitimate safety concerns linger[ing]", such as new evidence ...
    Continue Reading
  • THE ENDOCRINE SOCIETY CALLS FOR REEVALUATION OF TESTOSTERONE THERAPY RISKS

    The Endocrine Society has issued a statement highlighting the need for robust evaluation of the risks associated with testosterone therapy (TT). In it, the Society recommends that "patients should be made aware of the potential risk of cardiovascular events in middle-aged and older men who are taking or considering testosterone therapy for age-related decline in testosterone levels and symptoms." ...
    Continue Reading
  • TESTOSTERONE STUDY OBSERVED DISCREPANCY IN RISK REPORTED BY INDUSTRY FUNDED TRIALS COMPARED TO NON-INDUSTRY FUNDED TRIALS

    A recent study published in 2013 warned that the risk of cardiovascular events is increased in men who have been prescribed testosterone therapy. Such cardiovascular events included heart attacks, congestive heart failures, coronary artery diseases, arrhythmias, and other cardiovascular disorders. In particular, this robust systematic review found the risk was increased by 54% for cardiovascular ...
    Continue Reading
  • FDA WARNS OF RECALL OF ARTIFICIAL EMBOLIZATION DEVICE

    The FDA has classified the recent device correction notice for TRUFILL n-BCA as a Class I recall. TRUFILL n-BCA is a device used for the treatment of Arterio-Venous Malformations, such as abnormal connection between the arteries and veins in the brain. It is marketed by Codman Neuro, which is part of DePuy Synthes Companies. Codman Neuro has identified an incorrect statement in the product's ...
    Continue Reading
  • FDA Requires Design Changes To Fentanyl Patches

    September 23, 2013 - As part of its efforts to regulate dangerous pharmaceuticals, the FDA issued a drug safety communication requiring changes to the design of Duragesic (fentanyl) pain patches so that the patches can be seen more easily. Fentanyl patches are dangerous and prone to cause accidental exposure because they retain potent amounts of the active narcotic ingredient even after use. ...
    Continue Reading
  • McNeil Consumer Healthcare Recalls Motrin Infants Drops Due To Contamination

    The FDA recently announced a recall initiated by McNeil Consumer Healthcare that affects three lots of MOTRIN Infant's Drops (active ingredient: ibuprofen). The recall was prompted by the presence of "tiny plastic particles" identified during manufacturing. The particles were found in a lot that was not released on the market, but was part of the same batch as the three recalled lots. The ...
    Continue Reading
  • Cubist Pharmaceuticals Recalls An Antibiotic Due To Contamination

    The FDA recently announced a recall initiated by Cubist Pharmaceuticals, Inc. that affects four lots of Cubicin (daptomycin for injection). Cubicin is an antibiotic indicated for the treatment of certain types of infections. The recall was prompted by "the presence of [glass particulates] found in a number of vials" from the four lots. No adverse reactions associated with vials containing glass ...
    Continue Reading
  • Risk Of Permanent Nerve Damage From Antibacterial Fluoroquinolone Drugs

    The FDA recently issued a safety communication requiring label changes for all antibacterial drugs that contain fluoroquinolone and are taken orally or by injection. The label updates were prompted by FDA's recent evaluation of reports from its Adverse Event Reporting System database. The evaluation demonstrated that the existing label warnings do not adequately describe "the potential rapid onset ...
    Continue Reading
  • FDA Safety Alert On Certain Baczol Antigripal And Baczol Expectorante

    The FDA recently warned that consumers should not use Baczol Antigripal and Baczol Expectorante containing sulfamethoxazole, trimethoprim, or dipirona. The drugs in question are "labeled in Spanish and marketed as antibiotics for bronchitis, pneumonia, and other respiratory infections". Sulfamethoxazole and trimethoprim can cause serious or even life-threatening conditions such as "liver failure, ...
    Continue Reading
  • Voluntary Recall Of Estarylla Tablets

    A recent posting by the FDA informs that Sandoz, a Division of the Novartis group, has issued a voluntary recall of a batch of Estarylla tablets. Estarylla (norgestimate and ethinyl estradiol) is a combination oral contraceptive. The recall was prompted by a packaging flaw. In particular, the affected lot had placebo tablets mixed with regular tablets containing the active ingredients. According ...
    Continue Reading
  • Anti-Inflammatory Drug, Diclofenac, May Increase Risk Of Heart Attack

    A Committee of the European Medicines Agency recently concluded that diclofenac is associated with an increased risk of heart attacks compared to other non-steroidal anti-inflammatory drugs (NSAIDs). The conclusion, based on robust evidence, further states that increased vascular risks are particularly associated with high-dose or long-term use of the drug. Thus the Committee recommends that ...
    Continue Reading
  • Taking SSRIS During Pregnancy Could Increase Risk Of Birth Defects

    A recent publication by BBC News reports that "SSRIs can double the risk of a child being born with a heart defect." According to Prof. Stephen Pilling, an expert adviser to UK's National Institute for Health and Care Excellence (NICE), the risk increases from 2 in 100 (in the general population) to 4 in 100 in cases where the mother took an SSRI during early pregnancy. Prof. Pilling further warns ...
    Continue Reading
  • Popular Diabetes Drugs May Increase Risk For Pancreatic Cancer

    A recent investigation led by the British Medical Journal (BMJ) and UK's Channel 4 Dispatches raises concerns about the safety of several popular drugs used to treat type-2 diabetes. In particular, the investigation uncovered evidence that exenatide (marketed in the US as Byetta and Bydureon) and liraglutide (marketed in the US as Victoza) might increase the risk for pancreatic cancer and other ...
    Continue Reading
  • Compounding Pharmacies Forced To Recall Tainted Drugs

    Several compounding pharmacies across the country were recently forced to recall their products after federal inspectors found sanitation issues at their facilities. Compounding pharmacies mix sterile specialty drugs for patients who had specific prescriptions. Last year, filthy conditions at a New England compounding pharmacy resulted in a multistate fungal meningitis outbreak that killed 53 ...
    Continue Reading
  • Experts Weigh The Risks, Side Effects Of Oral Birth Control Pills

    Regulators around the world are taking a closer look at birth control pills that may expose women to an increased risk of blood clots and strokes. Many product liability lawsuits have arisen out of the newer forms of birth control pills, which are known as third- and fourth-generation pills. Reuters reports that many medical experts consider the newer forms of these pills to be more dangerous than ...
    Continue Reading
Page 1 of 2